Heat shock proteins transfer peptides during antigen processing and CTL priming (original) (raw)
References
Ang, D., Liberek, K., Skowyra, D., Zylicz, M., and Georgopoulos, C. Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem 266: 24233–24236, 1991 Google Scholar
Basombrío, M. A. Search for common antigenicities among 25 sarcomas induced by methylcholanthrene. Cancer Res 30: 2458–2462, 1970 Google Scholar
Bevan, M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not crossreact in the cytotoxic assay. J Exp Med 143: 1283–1288, 1976 Google Scholar
Blachere, N. E., Udono, H., Janetzki, S., Li, Z., Heike, M. and Srivastava, P. K. Heat shock protein vaccines against cancer. J Immunotherapy, in press. 1993
Burnet, F. M. A certain symmetry: histocompatibility antigens compared with immunocyte receptors. Nature 226: 123–126, 1970 Google Scholar
Cerundolo, V., Elliott, T., Elvin, J., Bastin, H., Rammensee, H. G., and Townsend, A. The binding affinity and dissociation rates of peptides for MHC class I molecules. Eur J Immunol 21: 2069–2075, 1991 Google Scholar
Christnick, E. R., Luscher, M. A., Barber, B. H., and Williams, D. B. Peptide-binding to MHC class I on living cells and quantitation of complexes required for CTL lysis. Nature 352: 67–70, 1991 Google Scholar
Darrow, T. L., Slingluff, C. L., and Siegler, H. F. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific T lymphocytes: evidence for shared tumor antigens. J Immunol 142: 3329–3334, 1989 Google Scholar
Falk, K., Rötschke, O., and Rammensee, H. G. Cellular peptide composition governed by MHC class I molecules. Nature 348: 248–251, 1990 Google Scholar
Feldweg, A. M. and Srivastava, P. K. Molecular heterogeneity of tumor rejection antigen/heat shock protein gp96. J Cell Biochem 170: 108, 1993 Google Scholar
Flajnik, M. F., Canel, C., Kramer, J., and Kasahara, M. Which came first, MHC class I or class II? Immunogenetics 33: 295–301, 1991 a Google Scholar
Flajnik, M. F., Canel, C., Kramer, J., and Kasahara, M. Evolution of the MHC: molecular cloning of MHC class I from the amphibian Xenopus, Proc Natl Acad Sci USA 88: 537–541, 1991 b Google Scholar
Flynn, G. C., Chappell, T. G., and Rothman, J. E. Peptide binding and release by proteins implicated as catalysts of protein assembly. Science 245: 385–388, 1989 Google Scholar
Flynn, G. C., Pohl, J., Flocco, M. T., and Rothman, J. E. Peptide binding specificity of the molecular chaperone BiP. Nature 353: 726–730, 1991 Google Scholar
Forsdyke, D. R. Relationship of X chromosome dosage compensation t to intracellular self/non self discrimination. J Theor Biol, in press, 1993 a
Forsdyke, D. R. The heat shock response and the molecular basis of genetic dominance. J Theor Biol, in press, 1993 b
Globerson, A. and Feldman, M. Antigenic specificity of benzo(a)pyrene induced sarcomas. J Natl Cancer Inst 32: 1229–1243, 1964 Google Scholar
Glynne, R., Powis, S. H., Beck, S., Kelly, A., Kerr, L. A., and Trowsdale, J. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353: 357–360, 1991 Google Scholar
Gooding, L. R. and Edwards, C.B. H-2 antigen requirement in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol 124: 1258–1262, 1980 Google Scholar
Gooding, L. R. and Wold, W. S. M. Molecular mechanisms by which adenoviruses counteract anti-viral immune defenses. CRC Crit Rev Immunol 10: 53–71, 1989 Google Scholar
Griem, P., Wallny, P., Falk, K., Rötzschke, O., Arnold, B., Schonrich, G., Hämmerling, G., and Rammensee, H. G. Uneven distribution of minor histocompatibility proteins versus peptides is caused by MHC expression. Cell 65: 633–640, 1991 Google Scholar
Gross, L. Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res 3: 323–326, 1943 Google Scholar
Kawakami, Y., Zakut, R., Topalian, S. L., Stotter, H., and Rosenberg, S. A. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol 148: 638–643, 1992 Google Scholar
Kelly, A., Powis, S., Glynne, R., Radley, E., Beck, S., and Trowsdale, J. Second proteasome-related gene in the human MHC class II region. Nature 353: 667–668, 1991 Google Scholar
Klein, G., Sjogren, H. O., Klein, E., and Hellstrom, K. E. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20: 1561–1572, 1960 Google Scholar
Lakey, E. K., Margoliash, E., and Pierce, S. K. Identification of a peptide binding protein that plays a role in antigen presentation. Proc Natl Acad Sci USA 84: 1659–1663, 1987 Google Scholar
Li, Z. and Srivastava, P. K. Tumor rejection antigen gp96/grp94 is an ATPase: Implications for antigen presentation and protein folding. EMBO J 12: 3143–3151, 1993 Google Scholar
Moore, S. K., Rijli, F., and Appella, E. Characterization of the mouse 84 kD heat shock protein gene family. DNA Cell Biol 9: 387–400, 1990 Google Scholar
Monaco, J. and McDevitt, H. O. The LMP antigens: a stable MHC controlled multi sub unit protein complex. Hum Immunol 15: 416–426, 1986 Google Scholar
Oettgen, H. F. and Old, L. J. The historu of cancer immunotherapy. In V. T. De Vita, S. A. Hellman, and S. A. Rosenberg (eds): Biological Therapy of Cancer, pp 87–119, J. B. Lippincott, Philadelphia, 1991 Google Scholar
Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A. Antigenic properties of chemically induced tumors. Ann NY Acad Sci 101: 80–106, 1962 Google Scholar
Palladino, M. A., Srivastava, P. K., Oettgen, H. F., and DeLeo, A. B. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res 47: 5074–5079, 1987 Google Scholar
Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., and Harding, C. V. Phagocytic processing for bacterial antigens for class I MHC presentation to T cells. Nature 361: 359–362, 1993 Google Scholar
Prehn, R. and Main, J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18: 769–778, 1957 Google Scholar
Raychaudhuri, S. and Morrow, W. J. W. Can soluble antigens induce CD8+ T cell response? A paradox revisited. Immunol Today 14: 344–348, 1993 Google Scholar
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., and Rammensee, H. G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348: 252–254, 1990 Google Scholar
Rötzschke, O., and Falk, K. Naturally occuring peptide antigens derived from the MHC class I-restricted processing pathway. Immunol Today 12: 447–455, 1991 Google Scholar
Rötzschke, O., Falk, K., Faath, S., and Rammensee, H. G. On the nature of proteins involved in T-cell alloreactivity. J Exp Med 174: 1059–1071, 1991 Google Scholar
Srivastava, P. K., and Das, M. R. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int J Cancer 33: 417–422, 1984 Google Scholar
Srivastava, P. K. and Heike, M. Tumor-specific immunogenicity of stress-—induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin Immunol 3: 57–64, 1991 Google Scholar
Srivastava, P. K. and Maki, R. G. Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol 167: 109–123, 1991 Google Scholar
Srivastava, P. K. and Old, L. J. Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today 9: 78–83, 1988 Google Scholar
Srivastava, P. K., De Leo, A. B., and Old, L. J. Tumor rejection antigens of chemically induced tumors of inbred mice. Proc Natl Acad Sci 83: 3407–3807, 1986 Google Scholar
Srivastava, P. K., Chen, Y. T., and Old, L. J. 5′ Structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proc Natl Acad Sci USA 84: 3804–3807, 1987 Google Scholar
Tanaka, K., Yoshioka, T., Bieberich, C. and Jay, G. Role of the MHC class I antigens in tumor growth and metastasis. Annu Rev Immunol 6: 359–380, 1988 Google Scholar
Townsend, A. and Bodner, H. Antigen presentation by class I-restricted T lymphocytes. Annu Rev Immunol 7: 601–624, 1989 CASPubMed Google Scholar
Udono, H. and Srivastava, P. K. Heat shock protein 70-associated peptides elicit cancer-specific immunity. J Exp Med 178: 1391–1396, 1993 Google Scholar
Udono, H., Levey, D. L., and Srivastava, P. K. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes naive CD8+ T cells in vivo. Proc Natl Acad Sci USA: in press, 1994
Ullrich, S. J., Robinson, E. A., Law, L. W., Willingham, M., and Appella, E. A mouse tumor-specific transplantation antigen is a heat-shock related protein. Proc Natl Acad Sci USA 83: 3121–3125, 1986 Google Scholar
Von Boehmer, H. Developmental biology of T cells in T-cell receptor transgenic mice. Annu Rev Immunol 8: 531–556, 1990 Google Scholar
Zinkernagel, R. and Doherty, P. Restriction of in vitro T-cell mediated cutotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature 248: 701–702, 1974 CASPubMed Google Scholar